Comment on ‘The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study'

Comment on ‘The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study’

• Publication year

  2016

• Venue

  British Journal of Cancer

• Publication date

  2016-07-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/bjc.2016.192PMID 27459694PMCID 4997539
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study

  2016cited by this paper
• Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy‐related leukemia

  2016cited by this paper
• The Mutational Landscape of Acute Promyelocytic Leukemia Reveals an Interacting Network of Co-Occurrences and Recurrent Mutations

  2016cited by this paper
• BRCA1, PARP1 and γH2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparib.

  2015cited by this paper
• High-Risk Human Papillomavirus Targets Crossroads in Immune Signaling

  2015cited by this paper
• Integrated molecular analysis of adult T cell leukemia/lymphoma

  2015cited by this paper
• Mutations in Breast Cancer Exome Sequences Predict Susceptibility to Infections and Converge on the Same Signaling Pathways

  2015cited by this paper
• Racial and ethnic differences in risk of second primary cancers among breast cancer survivors

  2015cited by this paper
• Lobulitis in nonneoplastic breast tissue from breast cancer patients: association with phenotypes that are common in hereditary breast cancer.

  2014cited by this paper
• Immune cell quantitation in normal breast tissue lobules with and without lobulitis

  2014cited by this paper
• Cervical Cancer Cell Supernatants Induce a Phenotypic Switch from U937-Derived Macrophage-Activated M1 State into M2-Like Suppressor Phenotype with Change in Toll-Like Receptor Profile

  2014cited by this paper
• Many Breast Cancer Mutations Parallel Mutations in Known Viral Cancers

  2014cited by this paper
• Fanconi anemia and the development of leukemia.

  2014cited by this paper
• High-risk human papillomavirus E6 inhibits monocyte differentiation to Langerhans cells.

  2013cited by this paper
• Mutations in components of antiviral or microbial defense as a basis for breast cancer

  2013cited by this paper
• HPV Infection: Immunological Aspects and Their Utility in Future Therapy

  2013cited by this paper
• Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008.

  2013influential reference
• Association of follicular lymphoma risk with BRCA2 N372H Polymorphism in Slovak population

  2012cited by this paper
• Comment on the review by Joshi and Buehring

  2012cited by this paper
• Sequence analysis of mutations and translocations across breast cancer subtypes

  2012cited by this paper
• Epstein-Barr Virus, Human Papillomavirus and Mouse Mammary Tumour Virus as Multiple Viruses in Breast Cancer

  2012influential reference
• Evidence That BRCA1- or BRCA2-Associated Cancers Are Not Inevitable

  2012cited by this paper
• The Fanconi Anemia Pathway Limits Human Papillomavirus Replication

  2012cited by this paper
• Prevalence of Human Papillomavirus in Breast Cancer: A Systematic Review

  2012cited by this paper
• Clonal evolution in relapsed acute myeloid leukemia revealed by whole genome sequencing

  2011cited by this paper
• The search for infectious causes of human cancers: where and why.

  2009cited by this paper
• Chromosome aberrations in peripheral blood lymphocytes of high‐risk HPV‐infected women with HGSIL

  2008cited by this paper
• The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers

  2007cited by this paper
• Distinct role of macrophages in different tumor microenvironments.

  2006cited by this paper
• Deficiencies in myeloid antigen‐presenting cells in women with cervical squamous intraepithelial lesions

  2006cited by this paper
• Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia

  2006cited by this paper
• Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia.

  2004cited by this paper
• In vitro infection of cells of the monocytic/macrophage lineage with bovine leukaemia virus.

  2000cited by this paper
• Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient.

  2000cited by this paper
• Chromosome fragility in lymphocytes of women with cervical uterine lesions produced by human papillomavirus.

  1992cited by this paper
• Risk of leukemia after chemotherapy and radiation treatment for breast cancer.

  1992influential reference

• Identifying Safeguards Disabled by Epstein-Barr Virus Infections in Genomes From Patients With Breast Cancer: Chromosomal Bioinformatics Analysis

  2023cites this paper
• Neutrophils and polymorphonuclear myeloid-derived suppressor cells: an emerging battleground in cancer therapy

  2022cites this paper
• Maximizing Breast Cancer Therapy with Awareness of Potential Treatment-Related Blood Disorders.

  2020cites this paper
• Treatment of BRCA1/2-associated breast cancer and identification of mutation carriers among breast cancer patients

  2017cites this paper
• Treatment of BRCA 1 / 2-associated breast cancer and identification of mutation carriers among breast cancer patients

  2017cites this paper